Connor, Clark & Lunn Investment Management Ltd.
Position in ACRS — Aclaris Therapeutics, Inc.
CIK 1596800
VANCOUVER, A1
Position in ACRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,400,296
+$1,081,446 QoQ
Shares Held
1,209,886
-14.7% QoQ
Ownership
0.822%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#24
of 149 holders
Holding Since
Sep 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $648,992,404 across 104 Biotechnology names. ACRS ranks #25 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,236 | $67,175,777 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
684,236 | $54,253,072 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
625,569 | $50,990,129 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
420,063 | $49,176,775 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,465 | $26,478,625 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
97,698 | $23,913,539 | |
| 7 | INSM |
INSMED Inc
|
212,676 | $22,675,515 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
530,607 | $20,698,979 |
All Filings in ACRS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,400,296 | 1,209,886 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,318,850 | 1,418,360 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,316,833 | 1,434,164 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,028,546 | 1,067,656 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,131,930 | 797,134 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,323,466 | 865,011 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,253,871 | 908,819 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $382,266 | 332,406 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $127,138 | 115,580 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $124,958 | 100,773 | Shares | Sole | 2024-05-09 | |
| 2023-09-30 | $1,378,446 | 201,233 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,186,379 | 210,837 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,429,098 | 176,650 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $265,324 | 16,846 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $422,681 | 26,854 | Shares | Sole | 2022-11-10 | |
| 2020-09-30 | $81,147 | 31,575 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||